Correlation of quantitative pancreatic T1 value and HbA1c value in subjects with normal and impaired glucose tolerance

Yoshifumi Noda,Satoshi Goshima,Yusuke Tsuji,Kimihiro Kajita,Hiroshi Kawada,Nobuyuki Kawai,Yukichi Tanahashi,Masayuki Matsuo
DOI: https://doi.org/10.1002/jmri.26242
Abstract:Background: Signal intensity on T1 -weighted images (T1 WI) is associated with pancreatic fibrosis and HbA1c levels. Purpose: To evaluate the feasibility of the pancreatic T1 value for assessment of subjects with normal and impaired glucose tolerance (IGT). Study type: A prospective single-institution study. Population: In all, 95 consecutive patients with a known or suspected pancreatic disease. Field strength/sequences: 3T/fast pancreatic T1 mapping using a modified Look-Locker sequence. Assessment: Following the American Diabetes Association criteria, patients were classified into three groups, as follows: no-diabetes subject, HbA1c < 5.7%; prediabetes, 5.7% ≤ HbA1c < 6.5%; and type 2 diabetes mellitus (T2DM), HbA1c ≥ 6.5%. Pancreatic T1 value and signal intensity ratio (SIR = SIpancreas /SImuscle ) using T1 WI were compared with the HbA1c values. Statistical tests: Quantitative data were assessed with one-way analysis of variance, Fisher's and Mann-Whitney U tests, and receiver-operating characteristic analysis. Results: The pancreatic T1 value was significantly longer in T2DM than in no-diabetes and prediabetes subjects (P < 0.05) and was significantly longer in prediabetes than in no-diabetes subjects (P < 0.05). The mean pancreatic T1 value was significantly lower in the low-value group (HbA1c < 5.7%) (906.3 msec) compared with the high-value group (HbA1c ≥ 6.5%) (993.8 msec) (P < 0.0001). SIR on T1 WI was significantly higher in the low-value group compared with the high-value group (P = 0.029). The sensitivities, specificities, and area under the receiver-operating characteristic curve (AUCs) for differentiating the low- and high-value groups were 74.1%, 83.8%, and 0.82 in the pancreatic T1 values and 77.8%, 54.4%, and 0.63 in SIR on T1 WI, respectively. The specificity (P < 0.0001) and AUC (P = 0.0020) were significantly higher in the pancreatic T1 values than in SIR on T1 WI. Data conclusion: Pancreatic T1 value has the potential of being an imaging biomarker for the assessment of IGT. Level of evidence: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:711-718.
What problem does this paper attempt to address?